Trial Data Reveals the Limitations of Steroids in Giant Cell Arteritis Therapy
Updates on Giant Cell Arteritis
New Recommendations Guide Imaging in Large-Vessel Vasculitis
Higher Fracture Risk in Patients with Polymyalgia Rheumatica, Giant-Cell Arteritis
Tocilizumab Is Effective to Treat GCA
FDA Update: Romosozumab’s Uncertain Future; Plus Tocilizumab Approved for GCA
FDA Considers Tocilizumab for GCA & Piclidenoson Enters Phase 3 Trial for RA, Psoriasis
GCA Relapse Possible When Discontinuing Tocilizumab